Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (British Journal of Pharmaceutical Research) passed a stringent test of the quality of Peer review by rejecting a fake article (Link1, Link2, Link3). We applaud the dedication and hard work of our peer reviewers and editors to maintain the high standard of our journals. It was reported that out of total 304 journals, only 20 journals rejected the fake article after substantial peer review. We are happy that our journal was among these few successful journals along with industry leaders like PLoS One, Hindawi, etc. We believe that the result of this experiment also proved the efficacy of our Advanced OPEN peer review and ‘post-publication’ peer review system. Though the report is debated, as it did not include subscription journals, we normally support any effort to improve the quality and transparency of peer review.

About Us

SCIENCEDOMAIN international (SDI) publishes high-quality, OPEN peer-reviewed, OPEN access international journals in various sectors of science, technology and medicine (STM). Fast and Open access principle of SDI help to promote rapid propagation of most up-to-date research findings to the researchers worldwide without any financial barrier.